TTrialPathMatch Me to Trials
← Back to trials
RecruitingSchizophrenia

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

Eligible age

18–65 yrs

Accepts

All genders

Locations

10 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving behavioral and psychological symptoms of schizophrenia in adults.

Sponsor: Neurocrine Biosciences

Where it's recruiting

Arkansas

Bryant · Little Rock

California

Anaheim · Pico Rivera · San Diego · Sherman Oaks …

Florida

Hollywood · Miami Lakes

Georgia

Atlanta · Decatur · Snellville

Illinois

Chicago

Maryland

Gaithersburg

Massachusetts

Watertown

New Jersey

Marlton

New York

Staten Island · The Bronx

Texas

Austin · DeSoto · Houston

Source: ClinicalTrials.gov · NCT06963034 · last updated 2026-03-06